* Repligen Corp RGEN.OQ RGEN.O is expected to show a
fall in
quarterly revenue when it reports results on July 30 for the
period ending June 30 2024
* The Waltham Massachusetts-based company is expected to
report a
3.2% decrease in revenue to $154.121 million from $159.17
million a year ago, according to the mean estimate from 14
analysts, based on LSEG data.
* LSEG's mean analyst estimate for Repligen Corp is for
earnings
of 33 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 12 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Repligen
Corp is
$197.79, above its last closing price of $132.36.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Mar. 31 2024 0.30 0.30 0.28 Missed -7.2
Dec. 31 2024 0.33 0.33 0.33 Met 1.4
Sep. 30 2023 0.17 0.17 0.23 Beat 38.7
Jan. 1 0001 0.48 0.48 0.53 Beat 11.5
Mar. 0.59 0.59 0.64 Beat 9
31 2023
Dec. 31 2022 0.57 0.58 0.68 Beat 17.8
Sep. 30 2022 0.68 0.68 0.77 Beat 13.2
Jun. 30 2022 0.72 0.72 0.91 Beat 27
This summary was machine generated July 26 at 14:35 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)